A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Trial Profile

A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs Fluocinolone acetonide (Primary)
  • Indications Uveitis
  • Focus Registrational; Therapeutic Use
  • Sponsors pSivida
  • Most Recent Events

    • 22 Dec 2016 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
    • 22 Dec 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Aug 2017.
    • 22 Dec 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top